"The U.S. Food and Drug Administration today approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection.
Tivicay is an integrase strand transfer inhibitor that interferes with one of the enzymes necessary for HIV to multiply. "...
Selzentry Patient Information including How Should I Take
In this Article
- What is maraviroc (Selzentry)?
- What are the possible side effects of maraviroc (Selzentry)?
- What is the most important information I should know about maraviroc (Selzentry)?
- What should I discuss with my health care provider before taking maraviroc (Selzentry)?
- How should I take maraviroc (Selzentry)?
- What happens if I miss a dose (Selzentry)?
- What happens if I overdose (Selzentry)?
- What should I avoid while taking maraviroc (Selzentry)?
- What other drugs will affect maraviroc (Selzentry)?
- Where can I get more information?
What should I discuss with my health care provider before taking maraviroc (Selzentry)?
You should not use this medication if you are allergic to it.
To make sure you can safely take maraviroc, tell your doctor if you have any of these other conditions:
- kidney disease;
- liver disease, especially hepatitis B or C;
- heart disease;
- low blood pressure;
- any type of allergy;
- circulation problems; or
- if you have ever had a stroke.
FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby, but HIV can be passed to your baby if you are not properly treated during pregnancy. Take all of your HIV medicines as directed to control your infection.
If you are pregnant, your name may be listed on a pregnancy registry. This is to track the outcome of the pregnancy and to evaluate any effects of maraviroc on the baby.
Women with HIV or AIDS should not breast-feed a baby. Even if your baby is born without HIV, the virus may be passed to the baby in your breast milk.
How should I take maraviroc (Selzentry)?
Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.
You may take maraviroc with or without food. Maraviroc is usually taken twice per day. Follow your doctor's instructions.
Do not crush, chew, or break the maraviroc tablet. Swallow the pill whole.
Use maraviroc regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.
HIV/AIDS is usually treated with a combination of different drugs. Maraviroc must be given in combination with other antiviral medications and it should not be used alone. Use all medications as directed by your doctor. Read the medication guide or patient instructions provided with each medication. Do not change your doses or medication schedule without your doctor's advice. Every person with HIV or AIDS should remain under the care of a doctor.
Store at room temperature away from moisture and heat.
Additional Selzentry Information
- Selzentry Drug Interactions Center: maraviroc oral
- Selzentry Side Effects Center
- Selzentry Overview including Precautions
- Selzentry FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.